Preferred Label : Iga nephropathy, susceptibility to, 1;
Symbol : IGAN1;
CISMeF acronym : IGAN; IGAN1;
Type : Phenotype or locus, molecular basis unknown;
Alternative titles and symbols : Nephritis, iga type; Berger disease; IGAN;
Description : End-stage renal disease (ESRD) is a major public health problem, affecting 1 in 1,000
individuals and with an annual death rate of 20% despite dialysis treatment. IgA nephropathy
(IgAN) is the most common form of glomerulonephritis, a principal cause of ESRD worldwide,
affecting up to 1.3% of the population. Kidneys of patients with IgA nephropathy show
deposits of IgA-containing immune complexes with proliferation of the glomerular mesangium.
Typical clinical features include onset before age 40 with hematuria and proteinuria,
and episodes of gross hematuria following mucosal infections are common; 30% of patients
develop progressive renal failure. Although not generally considered a hereditary
disease, striking ethnic variation in prevalence (Julian et al., 1985; D'Amico, 1987)
and familial clustering (Scolari et al., 1999), along with subclinical renal abnormalities
among relatives of cases, suggest a genetic component (Gharavi et al., 2000). - Genetic
Heterogeneity of IgA Nephropathy A locus for familial IgA nephropathy, called IGAN1,
on 6q22-q23, was described by Gharavi et al. (2000). Another locus, IGAN2 (613944),
was identified by Paterson et al. (2007) on chromosome 2q36. Polymorphisms in the
ACE (106180) and AGT (106150) genes have been associated with progression to chronic
renal failure in patients with IgA nephropathy.;
Inheritance : ?Autosomal dominant;
Laboratory abnormalities : Hematuria, macroscopic and microscopic; Proteinuria;
Prefixed ID : %161950;
Origin ID : 161950;
UMLS CUI : C3160719;
Currated CISMeF NLP mapping
DO Cross reference
False automatic mappings
HPO term(s)
ORDO concept(s)
See also inter- (CISMeF)
Semantic type(s)